Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2001

Study Completion Date

June 30, 2006

Conditions
Colorectal Cancer
Interventions
DRUG

gefitinib

Trial Locations (16)

10010

Veterans Affairs Medical Center - New York, New York

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

37212

Veterans Affairs Medical Center - Tennessee Valley Healthcare System - Nashville Campus, Nashville

53705

Veterans Affairs Medical Center - Madison, Madison

58122

CCOP - Merit Care Hospital, Fargo

60201

CCOP - Evanston, Evanston

60611

Veterans Affairs Medical Center - Lakeside Chicago, Chicago

62526

CCOP - Central Illinois, Decatur

60611-3013

Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago

49007-3731

CCOP - Kalamazoo, Kalamazoo

08903

Cancer Institute of New Jersey, New Brunswick

44106-5065

Ireland Cancer Center, Cleveland

19104-4283

University of Pennsylvania Cancer Center, Philadelphia

15213-3489

University of Pittsburgh Cancer Institute, Pittsburgh

37232-6838

Vanderbilt-Ingram Cancer Center, Nashville

53792-6164

University of Wisconsin Comprehensive Cancer Center, Madison

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Eastern Cooperative Oncology Group

NETWORK

NCT00025350 - Gefitinib in Treating Patients With Recurrent Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter